Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Metabolic Biomarkers in Predicting Twelve-Month Outcomes of Vital Pulp Treatment in Symptomatic Teeth With Carious Pulp Exposure: A Controlled Clinical Trial

NCT07452614 is registered in ClinicalTrials.gov with Abeer Ghalib Abdul-khaliq as lead sponsor.

NCT NCT07452614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07452614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Metabolic Biomarkers in Predicting Twelve-Month Outcomes of Vital Pulp Treatment in Symptomatic Teeth With Carious Pulp Exposure: A Controlled Clinical Trial
Lead sponsor
Abeer Ghalib Abdul-khaliq
Phase
Not applicable
Overall status
Recruiting
Start date
February 20, 2026
Completion date
October 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irreversible pulpitis (toothache), pulp disease, dental, pulpitis, reversible pulpitis